Potential heart health role for cranberry juice

6 July 2008

New data presented at Experimental Biology suggest that a double serving of light cranberry juice cocktail can potentially increase artery dilation and blood flow immediately after consumption. Researchers from Tufts University and Boston University presented data at the multi-disciplinary conference held in San Diego, USA, showing that the natural flavonoids in the juice are absorbed and were responsible for this benefit.

According to US agricultural cooperative Ocean Spray, 60 million Americans suffer from cardiovascular disease and this preliminary study suggests low-calorie cranberry juice may present an effective dietary tool for supporting blood vessel function.

In the preliminary study, researchers administered a double serving of light cranberry juice to patients with coronary artery disease and, over the next several hours, found the juice helped reverse an impairment in blood vessels by increasing their ability to dilate and carry more blood. This impairment in patients with coronary artery disease and those at risk of heart disease is called endothelial dysfunction and is characterized by a constriction of blood vessels that results in elevated blood pressure, which can exacerbate heart problems.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight